Status:
COMPLETED
Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)
Lead Sponsor:
Bayer
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-64 years
Phase:
PHASE4
Brief Summary
Evaluating the efficacy of 10mg vardenafil versus 10mg tadalafil in the first 45 minutes post-dosing, in an as-required regimen for 4 weeks in subjects with mild/moderate to severe ED
Eligibility Criteria
Inclusion
- Age between 18 and 64 years
- Heterosexual males
- Erectile dysfunction for more than 6 months
Exclusion
- Penile anatomical abnormalities
- Spinal cord injury
- History of surgical prostatectomy
Key Trial Info
Start Date :
April 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2004
Estimated Enrollment :
759 Patients enrolled
Trial Details
Trial ID
NCT00663130
Start Date
April 1 2004
End Date
July 1 2004
Last Update
October 11 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.